line_item,period,value,symbol
Tax Effect Of Unusual Items,2024-03-31 00:00:00,-3654349.178011,ZENITHDRUG.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.282407,ZENITHDRUG.NS
Normalized EBITDA,2024-03-31 00:00:00,190374000.0,ZENITHDRUG.NS
Total Unusual Items,2024-03-31 00:00:00,-12940000.0,ZENITHDRUG.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,-12940000.0,ZENITHDRUG.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,95928000.0,ZENITHDRUG.NS
Reconciled Depreciation,2024-03-31 00:00:00,13031000.0,ZENITHDRUG.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,855072000.0,ZENITHDRUG.NS
EBITDA,2024-03-31 00:00:00,177434000.0,ZENITHDRUG.NS
EBIT,2024-03-31 00:00:00,164403000.0,ZENITHDRUG.NS
Net Interest Income,2024-03-31 00:00:00,-29973000.0,ZENITHDRUG.NS
Interest Expense,2024-03-31 00:00:00,29973000.0,ZENITHDRUG.NS
Interest Income,2024-03-31 00:00:00,,ZENITHDRUG.NS
Normalized Income,2024-03-31 00:00:00,105213650.821989,ZENITHDRUG.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,95928000.0,ZENITHDRUG.NS
Total Expenses,2024-03-31 00:00:00,1160077000.0,ZENITHDRUG.NS
Rent Expense Supplemental,2024-03-31 00:00:00,,ZENITHDRUG.NS
Diluted Average Shares,2024-03-31 00:00:00,,ZENITHDRUG.NS
Basic Average Shares,2024-03-31 00:00:00,,ZENITHDRUG.NS
Diluted EPS,2024-03-31 00:00:00,,ZENITHDRUG.NS
Basic EPS,2024-03-31 00:00:00,,ZENITHDRUG.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,95928000.0,ZENITHDRUG.NS
Net Income Common Stockholders,2024-03-31 00:00:00,95928000.0,ZENITHDRUG.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income,2024-03-31 00:00:00,95928000.0,ZENITHDRUG.NS
Minority Interests,2024-03-31 00:00:00,-538000.0,ZENITHDRUG.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,96466000.0,ZENITHDRUG.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income Continuous Operations,2024-03-31 00:00:00,96466000.0,ZENITHDRUG.NS
Tax Provision,2024-03-31 00:00:00,37964000.0,ZENITHDRUG.NS
Pretax Income,2024-03-31 00:00:00,134430000.0,ZENITHDRUG.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,21222000.0,ZENITHDRUG.NS
Special Income Charges,2024-03-31 00:00:00,-12940000.0,ZENITHDRUG.NS
Other Special Charges,2024-03-31 00:00:00,12940000.0,ZENITHDRUG.NS
Write Off,2024-03-31 00:00:00,,ZENITHDRUG.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-29973000.0,ZENITHDRUG.NS
Total Other Finance Cost,2024-03-31 00:00:00,,ZENITHDRUG.NS
Interest Expense Non Operating,2024-03-31 00:00:00,29973000.0,ZENITHDRUG.NS
Interest Income Non Operating,2024-03-31 00:00:00,,ZENITHDRUG.NS
Operating Income,2024-03-31 00:00:00,156120000.0,ZENITHDRUG.NS
Operating Expense,2024-03-31 00:00:00,305005000.0,ZENITHDRUG.NS
Other Operating Expenses,2024-03-31 00:00:00,231118000.0,ZENITHDRUG.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,13031000.0,ZENITHDRUG.NS
Depreciation Income Statement,2024-03-31 00:00:00,13031000.0,ZENITHDRUG.NS
Selling General And Administration,2024-03-31 00:00:00,,ZENITHDRUG.NS
Selling And Marketing Expense,2024-03-31 00:00:00,,ZENITHDRUG.NS
General And Administrative Expense,2024-03-31 00:00:00,,ZENITHDRUG.NS
Rent And Landing Fees,2024-03-31 00:00:00,,ZENITHDRUG.NS
Gross Profit,2024-03-31 00:00:00,461125000.0,ZENITHDRUG.NS
Cost Of Revenue,2024-03-31 00:00:00,855072000.0,ZENITHDRUG.NS
Total Revenue,2024-03-31 00:00:00,1316197000.0,ZENITHDRUG.NS
Operating Revenue,2024-03-31 00:00:00,1316197000.0,ZENITHDRUG.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,0.0,ZENITHDRUG.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.266859,ZENITHDRUG.NS
Normalized EBITDA,2023-03-31 00:00:00,102893000.0,ZENITHDRUG.NS
Total Unusual Items,2023-03-31 00:00:00,0.0,ZENITHDRUG.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,48804000.0,ZENITHDRUG.NS
Reconciled Depreciation,2023-03-31 00:00:00,13054000.0,ZENITHDRUG.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,781213000.0,ZENITHDRUG.NS
EBITDA,2023-03-31 00:00:00,102893000.0,ZENITHDRUG.NS
EBIT,2023-03-31 00:00:00,89839000.0,ZENITHDRUG.NS
Net Interest Income,2023-03-31 00:00:00,-23272000.0,ZENITHDRUG.NS
Interest Expense,2023-03-31 00:00:00,23272000.0,ZENITHDRUG.NS
Interest Income,2023-03-31 00:00:00,1600000.0,ZENITHDRUG.NS
Normalized Income,2023-03-31 00:00:00,48804000.0,ZENITHDRUG.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,48804000.0,ZENITHDRUG.NS
Total Expenses,2023-03-31 00:00:00,1067743000.0,ZENITHDRUG.NS
Rent Expense Supplemental,2023-03-31 00:00:00,703000.0,ZENITHDRUG.NS
Diluted Average Shares,2023-03-31 00:00:00,17148800.0,ZENITHDRUG.NS
Basic Average Shares,2023-03-31 00:00:00,17148800.0,ZENITHDRUG.NS
Diluted EPS,2023-03-31 00:00:00,2.845913,ZENITHDRUG.NS
Basic EPS,2023-03-31 00:00:00,2.845913,ZENITHDRUG.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,48804000.0,ZENITHDRUG.NS
Net Income Common Stockholders,2023-03-31 00:00:00,48804000.0,ZENITHDRUG.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income,2023-03-31 00:00:00,48804000.0,ZENITHDRUG.NS
Minority Interests,2023-03-31 00:00:00,4000.0,ZENITHDRUG.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,48803000.0,ZENITHDRUG.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income Continuous Operations,2023-03-31 00:00:00,48803000.0,ZENITHDRUG.NS
Tax Provision,2023-03-31 00:00:00,17764000.0,ZENITHDRUG.NS
Pretax Income,2023-03-31 00:00:00,66567000.0,ZENITHDRUG.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,12392000.0,ZENITHDRUG.NS
Special Income Charges,2023-03-31 00:00:00,0.0,ZENITHDRUG.NS
Other Special Charges,2023-03-31 00:00:00,,ZENITHDRUG.NS
Write Off,2023-03-31 00:00:00,-744000.0,ZENITHDRUG.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-23272000.0,ZENITHDRUG.NS
Total Other Finance Cost,2023-03-31 00:00:00,3649000.0,ZENITHDRUG.NS
Interest Expense Non Operating,2023-03-31 00:00:00,23272000.0,ZENITHDRUG.NS
Interest Income Non Operating,2023-03-31 00:00:00,1600000.0,ZENITHDRUG.NS
Operating Income,2023-03-31 00:00:00,77448000.0,ZENITHDRUG.NS
Operating Expense,2023-03-31 00:00:00,286530000.0,ZENITHDRUG.NS
Other Operating Expenses,2023-03-31 00:00:00,223861000.0,ZENITHDRUG.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,13054000.0,ZENITHDRUG.NS
Depreciation Income Statement,2023-03-31 00:00:00,13054000.0,ZENITHDRUG.NS
Selling General And Administration,2023-03-31 00:00:00,38366000.0,ZENITHDRUG.NS
Selling And Marketing Expense,2023-03-31 00:00:00,2156000.0,ZENITHDRUG.NS
General And Administrative Expense,2023-03-31 00:00:00,36210000.0,ZENITHDRUG.NS
Rent And Landing Fees,2023-03-31 00:00:00,703000.0,ZENITHDRUG.NS
Gross Profit,2023-03-31 00:00:00,363978000.0,ZENITHDRUG.NS
Cost Of Revenue,2023-03-31 00:00:00,781213000.0,ZENITHDRUG.NS
Total Revenue,2023-03-31 00:00:00,1145191000.0,ZENITHDRUG.NS
Operating Revenue,2023-03-31 00:00:00,1145191000.0,ZENITHDRUG.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,124070.360199,ZENITHDRUG.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.289884,ZENITHDRUG.NS
Normalized EBITDA,2022-03-31 00:00:00,76363000.0,ZENITHDRUG.NS
Total Unusual Items,2022-03-31 00:00:00,428000.0,ZENITHDRUG.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,428000.0,ZENITHDRUG.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,31382000.0,ZENITHDRUG.NS
Reconciled Depreciation,2022-03-31 00:00:00,13263000.0,ZENITHDRUG.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,749787000.0,ZENITHDRUG.NS
EBITDA,2022-03-31 00:00:00,76791000.0,ZENITHDRUG.NS
EBIT,2022-03-31 00:00:00,63528000.0,ZENITHDRUG.NS
Net Interest Income,2022-03-31 00:00:00,-17172000.0,ZENITHDRUG.NS
Interest Expense,2022-03-31 00:00:00,19469000.0,ZENITHDRUG.NS
Interest Income,2022-03-31 00:00:00,5221000.0,ZENITHDRUG.NS
Normalized Income,2022-03-31 00:00:00,31078070.360199,ZENITHDRUG.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,31382000.0,ZENITHDRUG.NS
Total Expenses,2022-03-31 00:00:00,855752000.0,ZENITHDRUG.NS
Rent Expense Supplemental,2022-03-31 00:00:00,51000.0,ZENITHDRUG.NS
Diluted Average Shares,2022-03-31 00:00:00,17148800.0,ZENITHDRUG.NS
Basic Average Shares,2022-03-31 00:00:00,17148800.0,ZENITHDRUG.NS
Diluted EPS,2022-03-31 00:00:00,1.829982,ZENITHDRUG.NS
Basic EPS,2022-03-31 00:00:00,1.829982,ZENITHDRUG.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,31382000.0,ZENITHDRUG.NS
Net Income Common Stockholders,2022-03-31 00:00:00,31382000.0,ZENITHDRUG.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income,2022-03-31 00:00:00,31382000.0,ZENITHDRUG.NS
Minority Interests,2022-03-31 00:00:00,96000.0,ZENITHDRUG.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,31286000.0,ZENITHDRUG.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,,ZENITHDRUG.NS
Net Income Continuous Operations,2022-03-31 00:00:00,31287000.0,ZENITHDRUG.NS
Tax Provision,2022-03-31 00:00:00,12772000.0,ZENITHDRUG.NS
Pretax Income,2022-03-31 00:00:00,44059000.0,ZENITHDRUG.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,1000.0,ZENITHDRUG.NS
Special Income Charges,2022-03-31 00:00:00,428000.0,ZENITHDRUG.NS
Other Special Charges,2022-03-31 00:00:00,-428000.0,ZENITHDRUG.NS
Write Off,2022-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-17172000.0,ZENITHDRUG.NS
Total Other Finance Cost,2022-03-31 00:00:00,2924000.0,ZENITHDRUG.NS
Interest Expense Non Operating,2022-03-31 00:00:00,19469000.0,ZENITHDRUG.NS
Interest Income Non Operating,2022-03-31 00:00:00,5221000.0,ZENITHDRUG.NS
Operating Income,2022-03-31 00:00:00,60798000.0,ZENITHDRUG.NS
Operating Expense,2022-03-31 00:00:00,105965000.0,ZENITHDRUG.NS
Other Operating Expenses,2022-03-31 00:00:00,41054000.0,ZENITHDRUG.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,13263000.0,ZENITHDRUG.NS
Depreciation Income Statement,2022-03-31 00:00:00,13263000.0,ZENITHDRUG.NS
Selling General And Administration,2022-03-31 00:00:00,17236000.0,ZENITHDRUG.NS
Selling And Marketing Expense,2022-03-31 00:00:00,1530000.0,ZENITHDRUG.NS
General And Administrative Expense,2022-03-31 00:00:00,15706000.0,ZENITHDRUG.NS
Rent And Landing Fees,2022-03-31 00:00:00,51000.0,ZENITHDRUG.NS
Gross Profit,2022-03-31 00:00:00,166763000.0,ZENITHDRUG.NS
Cost Of Revenue,2022-03-31 00:00:00,749787000.0,ZENITHDRUG.NS
Total Revenue,2022-03-31 00:00:00,916550000.0,ZENITHDRUG.NS
Operating Revenue,2022-03-31 00:00:00,916550000.0,ZENITHDRUG.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,-622379.109537,ZENITHDRUG.NS
Tax Rate For Calcs,2021-03-31 00:00:00,0.341779,ZENITHDRUG.NS
Normalized EBITDA,2021-03-31 00:00:00,74046000.0,ZENITHDRUG.NS
Total Unusual Items,2021-03-31 00:00:00,-1821000.0,ZENITHDRUG.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,-1821000.0,ZENITHDRUG.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,30292000.0,ZENITHDRUG.NS
Reconciled Depreciation,2021-03-31 00:00:00,12160000.0,ZENITHDRUG.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,534642000.0,ZENITHDRUG.NS
EBITDA,2021-03-31 00:00:00,72225000.0,ZENITHDRUG.NS
EBIT,2021-03-31 00:00:00,60065000.0,ZENITHDRUG.NS
Net Interest Income,2021-03-31 00:00:00,-15212000.0,ZENITHDRUG.NS
Interest Expense,2021-03-31 00:00:00,14044000.0,ZENITHDRUG.NS
Interest Income,2021-03-31 00:00:00,612000.0,ZENITHDRUG.NS
Normalized Income,2021-03-31 00:00:00,31490620.890463,ZENITHDRUG.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,30292000.0,ZENITHDRUG.NS
Total Expenses,2021-03-31 00:00:00,670332000.0,ZENITHDRUG.NS
Rent Expense Supplemental,2021-03-31 00:00:00,90000.0,ZENITHDRUG.NS
Diluted Average Shares,2021-03-31 00:00:00,17148800.0,ZENITHDRUG.NS
Basic Average Shares,2021-03-31 00:00:00,17148800.0,ZENITHDRUG.NS
Diluted EPS,2021-03-31 00:00:00,1.766421,ZENITHDRUG.NS
Basic EPS,2021-03-31 00:00:00,1.766421,ZENITHDRUG.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,30292000.0,ZENITHDRUG.NS
Net Income Common Stockholders,2021-03-31 00:00:00,30292000.0,ZENITHDRUG.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income,2021-03-31 00:00:00,30292000.0,ZENITHDRUG.NS
Minority Interests,2021-03-31 00:00:00,0.0,ZENITHDRUG.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,30292000.0,ZENITHDRUG.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,,ZENITHDRUG.NS
Net Income Continuous Operations,2021-03-31 00:00:00,30292000.0,ZENITHDRUG.NS
Tax Provision,2021-03-31 00:00:00,15729000.0,ZENITHDRUG.NS
Pretax Income,2021-03-31 00:00:00,46021000.0,ZENITHDRUG.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,528000.0,ZENITHDRUG.NS
Special Income Charges,2021-03-31 00:00:00,-1821000.0,ZENITHDRUG.NS
Other Special Charges,2021-03-31 00:00:00,,ZENITHDRUG.NS
Write Off,2021-03-31 00:00:00,1821000.0,ZENITHDRUG.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,-15212000.0,ZENITHDRUG.NS
Total Other Finance Cost,2021-03-31 00:00:00,1780000.0,ZENITHDRUG.NS
Interest Expense Non Operating,2021-03-31 00:00:00,14044000.0,ZENITHDRUG.NS
Interest Income Non Operating,2021-03-31 00:00:00,612000.0,ZENITHDRUG.NS
Operating Income,2021-03-31 00:00:00,63685000.0,ZENITHDRUG.NS
Operating Expense,2021-03-31 00:00:00,135690000.0,ZENITHDRUG.NS
Other Operating Expenses,2021-03-31 00:00:00,55324000.0,ZENITHDRUG.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,12160000.0,ZENITHDRUG.NS
Depreciation Income Statement,2021-03-31 00:00:00,12160000.0,ZENITHDRUG.NS
Selling General And Administration,2021-03-31 00:00:00,32645000.0,ZENITHDRUG.NS
Selling And Marketing Expense,2021-03-31 00:00:00,6634000.0,ZENITHDRUG.NS
General And Administrative Expense,2021-03-31 00:00:00,26011000.0,ZENITHDRUG.NS
Rent And Landing Fees,2021-03-31 00:00:00,90000.0,ZENITHDRUG.NS
Gross Profit,2021-03-31 00:00:00,199375000.0,ZENITHDRUG.NS
Cost Of Revenue,2021-03-31 00:00:00,534642000.0,ZENITHDRUG.NS
Total Revenue,2021-03-31 00:00:00,734017000.0,ZENITHDRUG.NS
Operating Revenue,2021-03-31 00:00:00,734017000.0,ZENITHDRUG.NS
